期刊文献+

兔实验性动脉粥样硬化进程中全血粘弹性改变的机制初探 被引量:3

Mechanisms of changes of whole blood viscoelasticity in atheroscherotic rabbits
下载PDF
导出
摘要 目的:了解兔实验性动脉粥样硬化(AS)进程中全血粘弹性的改变及其可能的机制。方法:高铁-硫酸显色法测定总胆固醇(Tch)浓度。膜蛋白含量测定用Lowry法。膜收缩蛋白(SP)含量测定用SDS-聚丙烯酰胺凝胶电泳法。结果:在AS进程中Tch浓度及AG2全血粘弹性(动粘度η’和弹性模量G’)明显升高,而钠泵活性及SP相对含量降低。Tch浓度与钠泵活性和SP含量间、G’与SP含量间(仅在较高角频率时)呈负相关关系,而钠泵活性与SP含量间、G’与η’间呈正相关关系。结论:Tch浓度的升高与钠泵活性降低间有密切关联,而它们的改变与SP含量降低有一定关系。 Abstract AIM:To investigate the changes of serum total cholesterol(Tch), erythrocyte membrane sodium pump activity (SPA), spectrin(SP) content, whole blood dynamic viscosity(η′) and dynamic modulus (G′) in the course of rabbit atherosclerosis (AS) METHODS:30 rabbits were given cholesterol 1g/d in attempting to obtain an experimental model of AS RESULTS:Tch concentration, η′ and G′ were elevated, while SPA and SP content of red blood cells decreased in the course of AS Tch concentration was negatively correlated with SPA and SP content, on the contrary, SPA was positively correlated with SP content but G′ was negatively correlated with SP content (only under the circumstances of higher ω) G′ was also positively correlated with η′ CONCLUSIONS: Hypercholesterol (Hch) is associated with the decrease in erythrocyte SPA and SP content Hch and the decrease of SPA and SP content play an important role in the course of AS by changing whole blood viscoelasticity MeSH Atherosclerosis; Cholesterol; Sodium; Spectrin
出处 《中国病理生理杂志》 CAS CSCD 北大核心 1998年第6期637-640,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金
  • 相关文献

参考文献3

  • 1范家骏,血液流变学基础与临床,1995年,101页
  • 2杨绍文,中国病理生理杂志,1990年,6卷,450页
  • 3张龙翔,生化实验方法和技术,1981年,21页

同被引文献12

  • 1何作云,于学军,李希楷,丁秋华.血小板内游离钙和cAMP在实验性动脉粥样硬化进程中的变化[J].中国应用生理学杂志,1993,9(4):354-355. 被引量:5
  • 2李健斋.血脂测定技术及其标准化的建议[J].中华心血管病杂志,1997,25(3):172-173.
  • 3Sparrow CP, Burton CA, Hemandez M, et al.Simvoztatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering[ J ]. Arterioscler-Thromb-Vasc-Biol. 2001, 21 ( 1 ) : 115 - 121.
  • 4Vita JA, Yeung AC, Winniford M, et al. Effect of cholesterol-lowering therapy on coronary endothdial vasomotor function in patients with coronary artery disease[J]. Circulation. 2000, 102(8) : 846 - 851.
  • 5Shida F, Watanabe K, Sato A, et al. Comparative effects of simvastatin(MK- 733) and pravastatin(CS - 514) on hypercholesterolemia induced by cholesterol feeding in rabbits [J]. Biochim Biophys Acta. 1990, 1042(3) :365 - 373.
  • 6Notarbartolo A, Day G, Averna M, et al. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type 1Ia hypercholesterolemia[J]. Arterioscler - Vase Biol. 1995, 15(2) : 247 - 251.
  • 7Milani M, Cimminiello C, Lorena M, et al. Effects of two different HMG -CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia[J]. Biomed Pharmacother. 1996, 50(6- 7) : 269- 274.
  • 8Cannon ROIII. Caniiovascular Benefit of Cholesterol-Lowering Therapy : Does Improved Endothelial Vasodilator Function Matter[J]? Circulation. 2000,102(8): 820-822.
  • 9Levy BD, Clish CB, Schmidt B, at al. Lipid mediator class switching during acute inflammation: signals in resolution[J]. Nat-Immunol. 2001,2(7) : 612- 619.
  • 10覃军,何作云,李隆贵,黄岚,周世文,黄永萍.国产辛伐他汀与舒降之治疗原发性高胆固醇血症的疗效比较[J].中国动脉硬化杂志,1999,7(4):348-350. 被引量:2

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部